{
    "xml": "<topic id=\"PHP85622\" outputclass=\"drug\" rev=\"1.16\" type=\"drug\" namespace=\"/drugs/isoniazid-with-rifampicin\" basename=\"isoniazid-with-rifampicin\" title=\"ISONIAZID WITH RIFAMPICIN\">\n<title>ISONIAZID WITH RIFAMPICIN </title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_165\" namespace=\"/interactions/list-of-drug-interactions/antibacterials/isoniazid\">Isoniazid</xref>, <xref format=\"dita\" href=\"#bnf_int_165\" namespace=\"/interactions/list-of-drug-interactions/antibacterials/isoniazid\">Isoniazid</xref>, <xref format=\"dita\" href=\"#bnf_int_201\" namespace=\"/interactions/list-of-drug-interactions/antibacterials/rifamycins/rifampicin\">Rifampicin</xref>, <xref format=\"dita\" href=\"#bnf_int_201\" namespace=\"/interactions/list-of-drug-interactions/antibacterials/rifamycins/rifampicin\">Rifampicin</xref>\n</p>\r\n<p outputclass=\"constituentDrugs\">The properties listed below are those particular to the combination only. For the properties of the components please consider, <xref format=\"dita\" href=\"#PHP3608\" namespace=\"/drugs/isoniazid\">isoniazid</xref>, <xref format=\"dita\" href=\"#PHP3619\" namespace=\"/drugs/rifampicin\">rifampicin</xref>.</p>\n<data name=\"vtmid\">346670008</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_951572631\" title=\"Hydrazides\">Hydrazides</xref>\n</data>\n</data>\r\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_467467039\" title=\"Rifamycins\">Rifamycins</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\r\n</body>\n<topic id=\"PHP87643\" outputclass=\"indicationsAndDose\" rev=\"1.38\" parent=\"/drugs/isoniazid-with-rifampicin\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Treatment of tuberculosis (continuation phase)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult (body-weight up to 50 kg)</p>\n<p>450/300&#8239;mg daily for 4 months (continuation phase after 2-month initial phase), use <i>Rifinah</i>\n<tm tmtype=\"reg\"/>\n<i>150/100</i> Tablets, preferably taken before breakfast.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult (body-weight 50 kg and above)</p>\n<p>600/300&#8239;mg daily for 4 months (continuation phase after 2-month initial phase), use <i>Rifinah</i>\n<tm tmtype=\"reg\"/>\n<i>300/150</i> Tablets, preferably taken before breakfast.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"doseEquivalence\">\n<title>Dose equivalence and conversion</title>\n<p>\n<i>Rifinah</i>\n<tm tmtype=\"reg\"/> Tablets contain rifampicin and isoniazid; the proportions are expressed in the form x/y where x and y are the strengths in milligrams of rifampicin and isoniazid respectively.</p>\n<p>Each <i>Rifinah</i>\n<tm tmtype=\"reg\"/>\n<i>150/100</i> Tablet contains rifampicin 150&#8239;mg and isoniazid 100&#8239;mg.</p>\n<p>Each <i>Rifinah</i>\n<tm tmtype=\"reg\"/>\n<i>300/150</i> Tablet contains rifampicin 300&#8239;mg and isoniazid 150&#8239;mg.</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP85622-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/isoniazid-with-rifampicin\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP92272\" title=\"Tablet\" namespace=\"/drugs/isoniazid-with-rifampicin/tablet\">Tablet</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"2\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78330\" namespace=\"/treatment-summaries/tuberculosis\" title=\"Tuberculosis\" count=\"1\" rel=\"backlink\">Tuberculosis</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_165\" namespace=\"/interactions/list-of-drug-interactions/antibacterials/isoniazid\" title=\"Isoniazid\" count=\"2\" rel=\"link\">Isoniazid</xref>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_201\" namespace=\"/interactions/list-of-drug-interactions/antibacterials/rifamycins/rifampicin\" title=\"Rifampicin\" count=\"2\" rel=\"link\">Rifampicin</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drug\" href=\"#PHP3608\" namespace=\"/drugs/isoniazid\" title=\"ISONIAZID\" count=\"1\" rel=\"link\">ISONIAZID</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drug\" href=\"#PHP3619\" namespace=\"/drugs/rifampicin\" title=\"RIFAMPICIN\" count=\"1\" rel=\"link\">RIFAMPICIN</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP92272\" namespace=\"/drugs/isoniazid-with-rifampicin/tablet\" title=\"Tablet\" count=\"1\" rel=\"link\">Tablet</xref>\n</links>\n</topic>",
    "id": "PHP85622",
    "outputclass": "drug",
    "rev": "1.16",
    "type": "drug",
    "namespace": "/drugs/isoniazid-with-rifampicin",
    "basename": "isoniazid-with-rifampicin",
    "title": "ISONIAZID WITH RIFAMPICIN",
    "interactants": [
        {
            "id": "bnf_int_165",
            "label": "Isoniazid"
        },
        {
            "id": "bnf_int_165",
            "label": "Isoniazid"
        },
        {
            "id": "bnf_int_201",
            "label": "Rifampicin"
        },
        {
            "id": "bnf_int_201",
            "label": "Rifampicin"
        }
    ],
    "constituents": [
        {
            "id": "PHP3608",
            "label": "isoniazid"
        },
        {
            "id": "PHP3619",
            "label": "rifampicin"
        }
    ],
    "vtmid": "346670008",
    "drugClassification": [
        "Hydrazides",
        "Rifamycins"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Treatment of tuberculosis (continuation phase)",
                        "html": "Treatment of tuberculosis (continuation phase)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "450/300 mg daily for 4 months (continuation phase after 2-month initial phase), use Rifinah 150/100 Tablets, preferably taken before breakfast.",
                        "html": "<p>450/300&#8239;mg daily for 4 months (continuation phase after 2-month initial phase), use <i>Rifinah</i> <tm tmtype=\"reg\"/> <i>150/100</i> Tablets, preferably taken before breakfast.</p>",
                        "ageGroup": "(body-weight up to 50 kg)"
                    },
                    {
                        "textContent": "600/300 mg daily for 4 months (continuation phase after 2-month initial phase), use Rifinah 300/150 Tablets, preferably taken before breakfast.",
                        "html": "<p>600/300&#8239;mg daily for 4 months (continuation phase after 2-month initial phase), use <i>Rifinah</i> <tm tmtype=\"reg\"/> <i>300/150</i> Tablets, preferably taken before breakfast.</p>",
                        "ageGroup": "(body-weight 50 kg and above)"
                    }
                ]
            }
        ],
        "doseEquivalence": [
            {
                "type": "doseEquivalence",
                "title": "Dose equivalence and conversion",
                "textContent": "Rifinah Tablets contain rifampicin and isoniazid; the proportions are expressed in the form x/y where x and y are the strengths in milligrams of rifampicin and isoniazid respectively.\n\nEach Rifinah 150/100 Tablet contains rifampicin 150 mg and isoniazid 100 mg.\n\nEach Rifinah 300/150 Tablet contains rifampicin 300 mg and isoniazid 150 mg.",
                "html": "<p>\n<i>Rifinah</i>\n<tm tmtype=\"reg\"/> Tablets contain rifampicin and isoniazid; the proportions are expressed in the form x/y where x and y are the strengths in milligrams of rifampicin and isoniazid respectively.</p><p>Each <i>Rifinah</i>\n<tm tmtype=\"reg\"/>\n<i>150/100</i> Tablet contains rifampicin 150&#8239;mg and isoniazid 100&#8239;mg.</p><p>Each <i>Rifinah</i>\n<tm tmtype=\"reg\"/>\n<i>300/150</i> Tablet contains rifampicin 300&#8239;mg and isoniazid 150&#8239;mg.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ]
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP92272",
                "label": "Tablet",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78330",
                "label": "Tuberculosis",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_165",
                "label": "Isoniazid",
                "type": "interaction"
            },
            {
                "id": "bnf_int_201",
                "label": "Rifampicin",
                "type": "interaction"
            }
        ],
        "drug": [
            {
                "id": "PHP3608",
                "label": "ISONIAZID",
                "type": "drug"
            },
            {
                "id": "PHP3619",
                "label": "RIFAMPICIN",
                "type": "drug"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP92272",
                "label": "Tablet",
                "type": "medicinalForm"
            }
        ]
    }
}